Vice President, Chief IP Counsel
Akebia Therapeutics (Cambridge, MA)
Henry Gu is Head of Intellectual Property at Akebia Therapeutics located in Cambridge, MA. Henry has extensive experience in the areas of IP litigation, IPR, patent prosecution, due diligence, IP counseling and opinion. Prior to joining Akebia, Henry was Assistant General Counsel, Head of IP at ARIAD Pharmaceuticals, where he managed key IP assets and was part of a team that led to the successful sale of the company to Takeda for $5.2 billion. Prior to ARIAD, he held positions of increasing responsibilities at Cubist Pharmaceuticals and Agios Pharmaceuticals. Prior to Cubist, Henry was Counsel at WilmerHale, where his practice focused on patent procurement, IP due diligence, and Hatch-Waxman litigation. Before that, Henry held an in-house position at Bristol-Myers Squibb in Princeton, NJ, where he worked on patent prosecution, lifecycle management and IP strategy. Henry also worked as a research scientist at BMS. He is an experienced inventor and has ten issued US patents.